Dynamics of the p53-Mdm2 feedback loop in individual cells

Nature Genetics

Volumn 36, Issue 2, 2004, Pages 147-150

  Lahav, Galit ^a   Rosenfeld, Nitzan ^a   Sigal, Alex ^a   Geva Zatorsky, Naama ^a   Levine, Arnold J ^b   Elowitz, Michael B ^c   Alon, Uri ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYAN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN MDM2; PROTEIN P53; REGULATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; YELLOW FLUORESCENT PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL POPULATION; CELL REGENERATION; CONTROLLED STUDY; DNA DAMAGE; FEEDBACK SYSTEM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR DYNAMICS; OSCILLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RADIATION DOSE; SIGNAL TRANSDUCTION; TECHNIQUE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEEDBACK, BIOCHEMICAL; FEMALE; GAMMA RAYS; HUMANS; IMMUNOBLOTTING; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0842332406     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1293     Document Type: Article

References (30)

1. Vogelstein, B., Lane, D. & Levine, A.J. Surfing the p53 network. Nature 408, 307-310 (2000).
2. Michael, D. & Oren, M. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 13, 49-58 (2003).
3. Piette, J., Neel, H. & Marechal, V. Mdm2: keeping p53 under control. Oncogene 15, 1001-1010 (1997).
4. Prives, C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8 (1998).
5. Momand, J., Wu, H.H. & Dasgupta, G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242, 15-29 (2000).
6. Larkin, N.D. & Jackson, S.P. Regulation of p53 in response to DNA damage. Oncogene 18, 7644-7655 (1999).
7. Ryan, K.M., Phillips, A.C. & Vousden, K.H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337 (2001).
8. Shen-Orr, S., Milo, R., Mangan, S. & Alon, U. Network motifs in the transcriptional regulation network of Escherichia coli. Nat. Genet. 31, 64-68 (2002).
9. Lev Bar-Or, R. et al. Generation of Oscillation by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc. Natl. Acad. Sci. USA 97, 11250-11255 (2000).
10. Hoffmann, A., Levchenko, A., Scott, M.L. & Baltimore, D. The |κB-NF-κB signaling module: Temporal control and selective gene activation. Science 298, 1241-1245 (2002).
11. Vojtesek, B. & Lane, D.P. Regulation of p53 protein expression in human breast cancer cell lines. J. Cell. Sci. 105, 607-612 (1993).
12. Mitsudomi, T. et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7, 171-180 (1992).
13. Zhang, T. & Prives, C. Cyclin a-CDK phosphorylation regulates MDM2 protein interactions. J. Biol. Chem. 276, 29702-29710 (2001).
14. Khosravi, R. et al. Rapid ATP-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. USA 96, 14973-14977 (1999).
15. Offer, H. et al. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res. 61, 88-96 (2001).
16. Reid, G. et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERa on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 605-707 (2003).
17. Goldbeter, A. Computational approaches to cellular rhythms. Nature 420, 238-245 (2002)
18. Ferrell, J.E. Jr. & Machleder, E.M. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280, 895-898 (1998).
19. Mihalas, G.I., Simon, Z., Balea, G. & Popa, E. Possible oscillatory behavior in p53-Mdm2 interaction computer simulation. J. Biol. Syst. 8, 21-29 (2000).
20. Mayo, L.D., Dixon, J.E., Durden, D.L., Tonks, N.K. & Donner, D.B. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277, 5484-5489 (2002).
21. Deguin-Chambon, V., Vacher, M., Jullien, M., May, E. & Bourdon, J.C. Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 19, 5831-5841 (2000).
22. Pomerening, J.R., Sontag, E.D. & Ferrell, J.E. Jr. Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol. 5, 346-351 (2003).
23. Tyson, J.J., Chen, K.C. & Novak, B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr. Opin. Cell Biol. 15, 221-231 (2003).
24. Andersen, R.D. et al. Metal dependent binding of a factor in vivo to the metal-responsive elements of the metallothionein 1 gene promoter. Mol. Cell Biol. 7, 3574-3581 (1987).
25. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L. & Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83 (1992).
26. Bonner, W.M. Low-dose rediation: thresholds, bystander effects, and adaptive responses. Proc. Natl. Acad. Sci. USA 100, 4973-4975 (2003).
27. Santoro, M.G. Heat shock factors and the control of the stress response. Biochem. Pharmacol. 59, 55-63 (2000).
28. Alcedo, J., Zou, Y. & Noll, M. Posttranscriptional regulation of Smoothened is part of a self-correcting mechanism in the Hedgehog signaling system. Mol. Cell 6, 457-465 (2000).
29. Guttman-Raviv, N., Matin, S. & Kassir, Y. Ime2, a meiosis-specific kinase in yeast, is required for destabilization of its transcriptional activator, Imel. Mol. Cell. Biol. 22, 2047-2056 (2002).
30. Straus, D., Walter, W. & Gross, C.A. DnaK, DnaJ, and GrpE heat shock proteins negatively regulate heat shock gene expression by controlling the synthesis and stability of sigma 32. Genes Dev. 4, 2202-2209 (1990).